The historic rise of Viagra has consistently remained a example of pharmaceutical success, however its legacy within the broader market now presents questions about potential gains. Copycat versions are eroding market share, causing concerns that investing in companies closely tied to Viagra's previous standing could be a dangerous move , especiall